Drug intelligence / Profile preview

Tuscold Jr

Development stage
Unknown
Lead developer
Med Manor Organics
Modality
Small Molecules
Administration
Oral
01

Overview

Tuscold Jr is a multi-ingredient pediatric cold formulation developed and marketed by Med Manor Organics. It is a fixed-dose combination containing paracetamol (acetaminophen), phenylephrine hydrochloride, chlorpheniramine maleate, and zinc gluconate. Paracetamol acts as an analgesic and antipyretic to reduce fever and relieve body aches. Phenylephrine hydrochloride is a decongestant that narrows blood vessels in the nasal passages to relieve congestion. Chlorpheniramine maleate is a first-generation antihistamine that blocks histamine H1 receptors to alleviate allergy symptoms such as sneezing, runny nose, and watery eyes. Zinc gluconate is included to support immune function and potentially reduce the duration and severity of common cold symptoms. Tuscold Jr is primarily indicated for the symptomatic relief of the common cold, flu, and upper respiratory tract allergies in pediatric patients.

Brand names
Tuscold JRTuscold-JR
Other names
chlorpheniramine + paracetamol + phenylephrine + zinc gluconate
02

Targets

ADRA1A (α1A)ADRA1B (α1B)ADRA1D (α1D)HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Tuscold Jr.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tuscold Jr.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call